About PNB Vesper
PNB Vesper is a company based in Kochi (India) founded in 2011. PNB Vesper has raised $918.51 thousand across 1 funding round. PNB Vesper operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Aclaris Therapeutics, among others.
- Headquarter Kochi, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pnb Vesper Life Science Private Limited
- Date of Incorporation 13 May, 2011
- Jurisdiction Cochin, Kerala, India
-
Annual Revenue
$4.11 K (USD)466.33as on Mar 31, 2023
-
Net Profit
-$50.5 K (USD)17.22as on Mar 31, 2023
-
EBITDA
-$34.49 K (USD)-213.65as on Mar 31, 2023
-
Total Equity Funding
$918.51 K (USD)
in 1 rounds
-
Latest Funding Round
$918.51 K (USD), Seed
Mar 29, 2013
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PNB Vesper
PNB Vesper has successfully raised a total of $918.51K through 1 strategic funding round. The most recent funding activity was a Seed round of $918.51 thousand completed in March 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by PNB Vesper
Investment portfolio details for PNB Vesper
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PNB Vesper
Detailed financials for PNB Vesper
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pnb Vesper Comparisons
Peer comparison for PNB Vesper
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PNB Vesper
PNB Vesper operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Aclaris Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Novel dermatologic therapies are developed for skin conditions.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
Detailed competitors of PNB Vesper
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pnb Vesper
Complete news archive for PNB Vesper
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PNB Vesper
PNB Vesper was founded in 2011 and raised its 1st funding round 2 years after it was founded.
PNB Vesper is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
Padinjarethalakkal Nanu Ezhuthassan Balaram is the current CEO of PNB Vesper.
PNB Vesper is a funded company, having raised a total of $918.51K across 1 funding round to date.
Annual revenue of PNB Vesper is $4.11K as on Mar 31, 2023.
Founded in 2011 in Kochi, India, therapies are developed by PNB Vesper for pain, cancer, inflammation, and neurological disorders in the biotechnology sector. Operations focus on drug candidates targeting gastrointestinal and oncology conditions. The lead product, PNB-001, a CCK2 antagonist, has completed phase I trials for IBSIBD and inflammatory pain. Additional candidates, PNB-028 and PNB-081, address pancreatic cancer, pancreatitis, and pain management.
PNB Vesper's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.